Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer

被引:20
|
作者
Ahyai, Sascha A. [1 ]
Zacharias, Mario [1 ]
Isbarn, Hendrik [1 ]
Steuber, Thomas [2 ]
Eichelberg, Christian [1 ]
Koellermann, Jens [3 ]
Fisch, Margit [1 ]
Karakiewicz, Pierre I. [4 ]
Huland, Hartwig [2 ]
Graefen, Markus [2 ]
Chun, Felix K. -H. [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Urol, D-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Martini Clin, Prostate Canc Ctr, D-20246 Hamburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, D-20246 Hamburg, Germany
[4] Univ Montreal, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
关键词
prostate cancer; tumour volume; biochemical recurrence; surgical margin; surgical volume; radical prostatectomy; RADICAL RETROPUBIC PROSTATECTOMY; TUMOR VOLUME; BIOCHEMICAL RECURRENCE; PROGRESSION; PREDICTORS; SPECIMENS; IMPACT; STAGE; MEN; EXTENSION;
D O I
10.1111/j.1464-410X.2009.09162.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To identify risk factors of a positive surgical margin (PSM) and the significance of a PSM after radical prostatectomy (RP) on biochemical recurrence (BCR) in exclusively pathologically confirmed organ-confined (OC) prostate cancer, as despite an excellent prognosis after RP, some patients with pathologically confirmed OC disease have BCR, and the prognostic significance of a PSM in these men remains unclear. PATIENTS AND METHODS We assessed 932 men with pathologically OC disease who were treated with RP by nine different surgeons between 1992 and 2004. The prognostic significance of clinical and pathological variables, including tumour volume (TV) and percentage of high-grade TV (%HGTV) were assessed. Logistic and Cox regression models were fitted to identify risk factors of a PSM and BCR. BCR was defined as a prostate-specific antigen (PSA) level of 0.1 ng/mL and increasing after an undetectable PSA level. RESULTS The total PSM rate was 12.9% (120 men); the mean TV (P < 0.001), but not %HGTV (P = 0.2) was significantly higher in patients with PSM. TV, nerve-sparing RP technique and surgical volume were independent risk factors for a PSM (P = 0.03). After a median follow-up of 35 months the overall BCR rate was 8.8% (82 men). Patients with a PSM had significantly higher BCR rates (21.7% vs 6.9%; P < 0.001). In univariable analysis, a high %HGTV (70.4%) was the most informative risk factor of BCR, followed by RP Gleason score (65.8%) and PSM (65.7%). Removal of PSM from a multivariable Cox model decreased the accuracy by 12.1% (P < 0.001). CONCLUSIONS Our findings show that in OC prostate cancer, the risk of a PSM depends on TV, surgical technique and surgical volume. PSM is a significant risk factor for BCR. However, only 20% men with OC disease and a PSM develop BCR; conversely, 80% of men are cured despite a PSM. Therefore, adjuvant therapy must be considered, with caution to avoid unnecessary overtreatment.
引用
收藏
页码:478 / 483
页数:6
相关论文
共 50 条
  • [1] Prognostic consequences of the location of positive surgical margins in organ-confined prostate cancer
    Salomon, L
    Anastasiadis, AG
    Antiphon, P
    Levrel, O
    Saint, F
    De La Taille, A
    Cicco, A
    Vordos, D
    Hoznek, A
    Chopin, D
    Abbou, CC
    UROLOGIA INTERNATIONALIS, 2003, 70 (04) : 291 - 296
  • [2] Significance of positive surgical margin on biochemical recurrence rates in organ confined prostate cancer
    Ahyai, Sascha
    Steuber, Thomas
    Chun, Felix K-H
    Walz, Jochen
    Schlomm, Thorsten
    Eichelberg, Christian
    Michl, Uwe
    Heinzer, Hans
    Martin, Friedrich
    Zacharias, Mario
    Haese, Alexander
    Graefen, Markus
    Huland, Hartwig
    JOURNAL OF UROLOGY, 2007, 177 (04): : 462 - 463
  • [3] Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ-confined prostate cancer
    Preisser, Felix
    Coxilha, Gilberto
    Heinze, Alexander
    Oh, Su
    Chun, Felix K-H
    Sauter, Guido
    Pompe, Raisa S.
    Huland, Hartwig
    Graefen, Markus
    Tilki, Derya
    PROSTATE, 2019, 79 (16): : 1832 - 1836
  • [4] IMPACT OF POSITIVE SURGICAL MARGIN LENGTH AND GLEASON GRADE AT THE MARGIN ON BIOCHEMICAL RECURRENCE IN PATIENTS WITH ORGAN-CONFINED PROSTATE CANCER
    Preisser, Felix
    Coxilha, Gilberto
    Heinze, Alexander
    Pompe, Raisa
    Chun, Felix
    Graefen, Markus
    Huland, Hartwig
    Tilki, Derya
    JOURNAL OF UROLOGY, 2019, 201 (04): : E872 - E872
  • [5] Prognostic Role of Perineural Invasion in 239 Consecutive Patients with Pathologically Organ-Confined Prostate Cancer
    Masieri, Lorenzo
    Lanciotti, Michele
    Nesi, Gabriella
    Lanzi, Federico
    Tosi, Nicola
    Minervini, Andrea
    Lapini, Alberto
    Carini, Marco
    Serni, Sergio
    UROLOGIA INTERNATIONALIS, 2010, 85 (04) : 396 - 400
  • [6] Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer
    Song, Cheryn
    Kang, Taejin
    Yoo, Sangjun
    Jeong, In Gab
    Ro, Jae Y.
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (02) : 168 - 174
  • [7] Oncological outcomes of pathologically organ-confined, lymph node-positive prostate cancer after radical prostatectomy
    Stolzenbach, Lara Franziska
    Knipper, Sophie
    Mandel, Philipp
    Ascalone, Luigi
    Deuker, Marina
    Tian, Zhe
    Heinzer, Hans
    Tilki, Derya
    Maurer, Tobias
    Graefen, Markus
    Karakiewicz, Pierre, I
    Steuber, Thomas
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (04) : 234.e1 - 234.e7
  • [9] PROGNOSTIC MEANING OF BENIGN AND MALIGNANT RESIDUAL GLANDULAR TISSUE ON SURGICAL BED AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICALLY ORGAN-CONFINED PROSTATE CANCER
    Valotto, C.
    Cerruto, M. A.
    Vianello, F.
    Brondani, G.
    Falconieri, G.
    Pizzolitto, S.
    Zattoni, F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 124 - 124
  • [10] Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: The basis for an adjuvant therapy trial
    DAmico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Tomaszewski, JE
    Wein, A
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1465 - 1469